Pharmacy (PHRM)
476 / 576.
Molecular and Cellular Pharmacology.
(3)
An overview of principles and basis of modern molecular and cellular pharmacology.
{Spring}
496.
Topics in Pharmacy.
(1 to a maximum of 3 Δ)
Restriction: permission of instructor.
497.
Problems in Pharmacy.
(1-5, no limit Δ)
Research and library problems in some phase of pharmacy. Not for professional students in the College of Pharmacy curriculum.
Restriction: permission of instructor.
498.
Problems in Pharmacy.
(1-5, no limit Δ)
Research and library problems in some phase of pharmacy. Not for professional students in the College of Pharmacy curriculum.
Restriction: permission of instructor.
507 / 707.
Pharmacy and Health Care Delivery.
(3)
Marketing and economic concepts of pharmacy practice, with a focus towards marketing of pharmaceutical services and products, pharmacy finance and economics in operations, pharmacoeconomics and decision-making.
511 / 773.
Nuclear Pharmacy Instrumentation.
(3)
Structure and properties of atoms, radiation and radioactive decay, production of radionuclides, interactions of radiation with matter, with emphasis on instrumentation for radiation detection and measurement in a nuclear pharmacy or nuclear medicine environment.
Restriction: permission of instructor.
512 / 774.
Radiopharmaceutical Chemistry.
(1)
Introduces undergraduate students to inorganic chemistry as applicable to radiopharmaceuticals.
Prerequisite: CHEM **302 or equivalent.
Restriction: permission of instructor.
513 / 775.
Radiation Biology and Radiation Safety.
(3)
Fundamentals of the biological effects of ionizing radiation on living systems, especially man; basic biological mechanisms which bring about somatic and genetic effects. Concepts of radiation protection, radiation dosimetry, radiation monitoring and x-ray health physics.
Restriction: permission of instructor.
516 / 776.
Radiopharmacology.
(3)
Study of the physicochemical characteristics of radiopharmaceuticals; kinetics of radiopharmaceuticals; structure-distribution relationships of radiopharmaceuticals; considerations in the design of new radiopharmaceuticals.
Restriction: permission of instructor.
521.
Radiopharmaceutics.
(2)
Study of the physicochemical characteristics of radiopharmaceuticals; kinetics of radiopharmaceuticals; structure-distribution relationships of radiopharmaceuticals; considerations in the design of new radiopharmaceuticals.
Restriction: permission of instructor.
523.
Clinical Nuclear Medicine.
(1)
The utility of nuclear medicine procedures in the diagnostic work-up of patients with various diseases is presented using case studies illustrated by data obtained from multiple imaging modalities.
Prerequisite: 511/773 and BIOL 238.
528 / 728.
Pharmacoepidemiology and Biomedical Literature Evaluation.
(3)
An examination of the structure of the biomedical literature and research with emphasis on the recognition, evaluation and application of different study types and the data they produce.
535.
Supplementary Training in Pharmaceutical Sciences.
(1)
This course provides supplementary training to PHRM 700-level courses through analysis of the relevant scientific literature. Course will require mastery of topics in PharmD courses with a focus on aspects of drug research and development.
Prerequisite: 706 and 710 and 731.
Corequisite: 732.
Restriction: permission of instructor.
536 / 736.
Introduction to Pharmacogenomics.
(2)
An introduction to how inherited variations in genes dictate drug response. Topics covered include basic principles of medical genetics, chemotherapy improvement through pharmacogenomics, as well as the ethical, legal, and social impact of pharmacogenomics.
545.
Pharmacoeconomics.
(3)
The course will discuss the theories, techniques and methodologies used to design, conduct and critique pharmacoeconomic and health outcomes research studies.
546.
Healthcare Systems Review.
(3)
An overview of the healthcare system, the pharmacy profession, and health services research. Students learn to evaluate research and develop skills in reviewing and summarizing literature regarding current and future problems in healthcare.
547.
Research Design and Analysis.
(3)
The course will provide training in research design and statistical methods used in conjunction with various studies. It will provide students with experience in the application of epidemiological and biostatistical methods available in SAS.
Prerequisite: EDPY 511.
Corequisite: PH 502.
548.
Ethics Clinical Trials-Informed Consent.
(2)
The study of the history, ethical versus scientific methodological conflicts, and other issues that are generated by the conduct of randomized controlled clinical trials using human beings.
549.
Regulatory Issues in Clinical Trials.
(2)
The study of federal regulations and guidelines that govern the planning and conduct of randomized controlled clinical trials in humans with drugs and devices.
551.
Fundamentals of Clinical Trials.
(3)
Advanced readings on topics relating to the pharmaceutical sciences in the area of the fundamental concepts and methods of designing, conducting, monitoring and closing out multicenter clinical trials.
Restriction: permission of instructor.
560 / 760.
Pharmacy Healthcare Management and Economics.
(3)
Provides students with an overview of the principles of marketing of pharmaceutical services, managed care pharmacy, pharmacoeconomics and outcomes research, and personnel management.
566 / 766.
Public Health in Pharmacy.
(2)
This course provides students with an introduction to public health from a pharmacy perspective.
570.
Multicenter Clinical Trials.
(4, may be repeated twice Δ)
The multicenter clinical trials (MCCT) experiential provides the pharmaceutical sciences graduate student applied training in multicenter clinical trials or cooperative studies.
576 / 476 [576].
Molecular and Cellular Pharmacology.
(3)
An overview of principles and basis of modern molecular and cellular pharmacology.
{Spring}
580.
General Toxicology.
(3)
An in-depth introduction to the basic principles and concepts of toxicology. Categories of chemicals causing toxic effects, the manner of exposure to toxic substances, the environmental and biological effects, and the laws and regulations will be considered.
591.
Seminar in Administrative Pharmacy.
(1, no limit Δ)
This course will give the students experience in organizing and presenting their thoughts and interpretations on a selected subject. The seminar will provide the student with an opportunity to develop writing and formal oral presentation skills.
Restriction: permission of instructor.
592.
Seminar in Radiopharmacy.
(1, no limit Δ)
Each masters candidate will be required to present a seminar on a topic of choice approved by his/her supervisor or selected by the supervisor.
Restriction: permission of instructor.
593.
Pharmaceutical Sciences and Toxicology Seminar.
(1, no limit Δ)
Research seminars on current topics in Toxicology will be presented by students and faculty from within UNM and from invited speakers outside of UNM.
Restriction: permission of instructor.
594.
Topics in Environmental Disease.
(1-3 to a maximum of 4 Δ)
Advanced readings in topics relating to toxicology and environmental disease, including areas such as chemical teratogenesis, reactive oxygen species, respiratory toxicology, receptor-medicated toxicology and environmentally induced cancer.
Prerequisite: 580.
Restriction: permission of instructor.
{Fall, Spring}
597.
Research Problems in Pharmaceutical Sciences.
(1-6, no limit Δ)
Research in pharmaceutical sciences.
Restriction: permission of instructor.
598.
Topics in Pharmaceutical Sciences.
(1-3 to a maximum of 4 Δ)
Advanced readings in topics relating to the pharmaceutical sciences in the areas of hospital pharmacy, pharmacy administration, radiopharmacy or toxicology.
Restriction: permission of instructor.
599.
Master's Thesis.
(1-6, no limit Δ)
Offered on a CR/NC basis only.
699.
Dissertation.
(1-9 to a maximum of 18 Δ)
Offered on a CR/NC basis only.
701.
Pharmaceutics I.
(3)
Study of pharmaceutical dosage forms and relevant physico-chemical and biopharmaceutical principles. Introduction to the metrology and calculations involved in the compounding and dispensing of pharmaceutical preparations.
702.
Pharmaceutics II.
(3)
Continuation of 701.
703L.
Pharmaceutical Care Lab I.
(3)
Introduction to the “languages and tools” used in contemporary pharmacy practice. Emphasis on calculations, communication, drug information, product formulation, and problem-solving.
704L.
Pharmaceutical Care Lab II.
(3)
Continuation of 703L with additional emphasis on patient information, assessment and monitoring; prescription processing; patient counseling; drug administration techniques; laboratory and home diagnostics tests; consult notes; and professional presentations.
705.
Pathophysiology.
(4)
Pathological consequences of disease states, including clinical presentation and histological findings presented by organ systems. Includes an introduction to medical terminology.
706.
Foundations of Drug Action.
(3)
An introduction to the molecular and chemical mechanisms of therapeutic agents. Topics include biochemical processes and drug targets, gene regulation and expression, cell signaling, and drug absorption, distribution, metabolism, and excretion processes.
707 / 507.
Pharmacy and Health Care Delivery.
(3)
Marketing and economic concepts of pharmacy practice, with a focus towards marketing of pharmaceutical services and products, pharmacy finance and economics in operations, pharmacoeconomics and decision-making.
709.
Introduction to Pharmacy Practice.
(1)
An introduction to the profession of pharmacy including career options, ethical principles, the responsibilities of being a health professional, the professional literature, and personal portfolio development.
710.
Mechanisms of Drug Action I.
(5)
First in a series of courses addressing principles of pharmacology, medicinal chemistry and biochemical mechanisms of drug action and toxicity. This section will specifically cover basics of drug metabolism and the pharmacology, structure-activity relationships (SAR), toxicology and elimination of drugs that act upon the autonomic nervous system.
713.
Pharmaceutical Calculations.
(1)
This course will introduce students to the knowledge and skills of fundamental mathematical calculations utilized in pharmacy practice.
715.
Pathophysiology II.
(4)
717.
Introductory Pharmacy Law.
(1)
An introduction to the Federal and New Mexico laws that relate to the practice of pharmacy.
718L.
Pharmaceutical Care Lab III.
(2)
Continuation of 704L. Activities parallel topics in concurrent self-care therapeutics and literature evaluation courses. Emphasis on patient assessment, care planning, and monitoring; critical literature appraisal; and written communication skills.
719.
Self-Care Therapeutics.
(2)
A pharmacotherapeutics course studying the use of non-prescription drugs, supplies, and herbal medicinals with emphasis on the pharmacist’s role as advisor, communicator, and educator to patients.
720.
Introduction to Nuclear Pharmacy.
(2)
This course provides an overview of nuclear pharmacy as a practice specialty: contributions of the nuclear pharmacist and application of radioactive tracer techniques in the diagnosis and treatment of disease will be reviewed.
721.
Self-Care Therapeutics II.
(1)
Self-Care involves the diagnosis, treatment, and prevention of one's own illness without professional expertise. This course will introduce the concept of pharmaceutical care by the use of life-style modification, over-the-counter medications, and natural remedies.
726.
Pharmacokinetics and Biopharmaceutics.
(3)
An introduction to the influence of absorption, distribution, metabolism, and excretion on the time course of drug levels in body and in understanding how changes in these processes affect the outcomes of drug therapies.
728 / 528.
Pharmacoepidemiology and Biomedical Literature Evaluation.
(3)
An examination of the structure of the biomedical literature and research with emphasis on the recognition, evaluation and application of different study types and the data they produce.
731.
Mechanisms of Drug Action II.
(5)
Continuation of 710 addressing pharmacology, toxicology, SAR and elimination of prototypes in specific drug classes.
732.
Mechanisms of Drug Action III.
(5)
Continuation of 710 and 731 addressing pharmacology, toxicology, SAR and elimination of prototypes in specific drug classes.
733L.
Pharmaceutical Care Lab IV.
(2)
Continuation of 718L. Activites parallel topics in concurrent pharmacotherapy drug course, with emphasis on patient assessment, care planning, and monitoring; self-care practices and verbal communication skills.
735.
Substance Abuse Elective.
(2)
This course emphasizes the most important themes and concepts in the field. Lectures/presentations will cover major categories of drug abuse (Opioids, Marijuana, Stimulants, Hallucinogenics, CNS depressants, Performance-enhancing drugs, OTC drugs, Herbals, Plants, and Tobacco/Caffeine/EtOH).
736 / 536.
Introduction to Pharmacogenomics.
(2)
An introduction to how inherited variations in genes dictate drug response. Topics covered include basic principles of medical genetics, chemotherapy improvement through pharmacogenomics, as well as the ethical, legal, and social impact of pharmacogenomics.
737.
Introductory Spanish in the Pharmacy.
(1)
This course provides the pharmacy student with the basic tools to communicate with Spanish-speaking patients. Pharmacy-specific vocabulary and helpful structures will be covered in addition to fundamental grammar and conversational skills.
738.
Intermediate Spanish in the Pharmacy.
(1)
A continuation of the introductory course. In addition to advancing the course participant's knowledge of basic medical terminology, the intermediate level introduces other relevant vocabulary topics for effective pharmacy communication in Spanish.
739.
Pharmacotherapy I.
(6)
Introduces students to a systematic approach to patient-centered pharmaceutical care, emphasizing patient assessment, problem-solving, communication, and counseling skills. Begins pharmacotherapy sequence.
740.
Self-Selected Supplementary Pharmacy Education.
(1-2 to a maximum of 2 Δ)
This course is designed to allow students to self-identify areas for supplemental pharmacy education. Student will select and complete ACPE-approved continuing education programs.
Offered on a CR/NC basis only.
748.
Research Project (Initial).
(1)
Student formulates hypothesis for research project and establishes methodologies for completion under guidance of faculty. Research project approved by committee.
Offered on a CR/NC basis only.
751.
Pharmacotherapy II.
(6)
Study of the therapy of common disease states by organ systems integrating the concepts from pathophysiology, pharmacology, biopharmaceutics, pharmacokinetics and pharmacoeconomics in the treatment of patients. Fully develops the concept of pharmaceutical care or how to provide the most cost-effective care of a patient including over-the-counter and natural remedies.
752.
Pharmacotherapy III.
(6)
Continuation of 751.
755.
Seminar in Pharmacy.
(1 to a maximum of 2 Δ)
Offered on a CR/NC basis only.
756.
Safe Medication Practices.
(2)
A study of the existence of medication errors, reasons for these errors and suggested methods to prevent them from occurring.
758.
Research Project.
(1)
Student completes research project in final year. Up to four students may work collaboratively on one project.
Offered on a CR/NC basis only.
759.
Advanced Law and Ethics.
(2)
Emphasis given to statues and regulations regulating the practice of pharmacy and distribution of drugs including the New Mexico Pharmacy Practice Act. Class discussion will include the application of ethics to situations in health care.
760 / 560.
Pharmacy Healthcare Management and Economics.
(3)
Provides students with an overview of the principles of marketing of pharmaceutical services, managed care pharmacy, pharmacoeconomics and outcomes research, and personnel management.
761.
Introduction to Managed Care Pharmacy Practice.
(2)
Issues critical to managed care pharmacy practice will be introduced such as: disease management, formulary management, drug utilization review, benefit design and contracting, Medicare and Medicaid, distribution systems and network management, quality improvement, health informatics.
762L.
Pharmaceutical Care Lab V.
(2)
Continuation of 733L, activities parallel concurrent pharmacotherapy courses. Emphasis on patient assessment, care planning, and monitoring.
764.
Emerging Technologies in Pharmaceutical Care.
(1)
Provides students with an understanding of the principles of biotechnology, pharmacogenomic, and other state of the art therapies in pharmacy.
765L.
Pharmaceutical Care Lab VI.
(2)
Continuation of 762L, activities parallel concurrent pharmacotherapy courses. Emphasis on patient assessment, care planning, and monitoring.
766 / 566.
Public Health in Pharmacy.
(2)
This course provides students with an introduction to public health from a pharmacy perspective.
769.
Pharmacy Practice Experience.
(0-4, may be repeated four times Δ)
Rotations that allow students to participate in patient-centered care activities in different settings that are in-depth, structured, and carefully coordinated with other components of the curriculum and require active participation in patient care responsibilities.
770.
Advanced Pharmacy Practice Experience.
(2-4 to a maximum of 36 Δ)
Consist of four-week clinical experiences (40 hours/week) where students provide direct pharmaceutical care to patients.
771.
Introductory Community Pharmacy Practice Experience.
(4)
A four-week (40 hours/week) directed dispensing pharmacy experience. Students will be exposed to ambulatory patient care in a community pharmacy setting.
Offered on a CR/NC basis only.
772.
Introductory Institutional Pharmacy Practice Experience.
(3 [4])
A four-week (40 hours/week) directed dispensing pharmacy experience. Students will be exposed to in-patient care in an institutional pharmacy setting.
Offered on a CR/NC basis only.
773 / 511.
Nuclear Pharmacy Instrumentation.
(3)
Structure and properties of atoms, radiation and radioactive decay, production of radionuclides, interactions of radiation with matter, with emphasis on instrumentation for radiation detection and measurement in a nuclear pharmacy or nuclear medicine environment.
Restriction: permission of instructor.
774 / 512.
Radiopharmaceutical Chemistry.
(1)
Introduces undergraduate students to inorganic chemistry as applicable to radiopharmaceuticals.
Prerequisite: CHEM **302.
Restriction: permission of instructor.
775 / 513.
Radiation Biology and Radiation Safety.
(3)
Fundamentals of the biological effects of ionizing radiation on living systems, especially man; basic biological mechanisms which bring about somatic and genetic effects. Concepts of radiation protection, radiation dosimetry, radiation monitoring and x-ray health physics.
Restriction: permission of instructor.
776 / 516.
Radiopharmacology.
(3)
Study of the physicochemical characteristics of radiopharmaceuticals; kinetics of radiopharmaceuticals; structure-distribution relationships of radiopharmaceuticals; considerations in the design of new radiopharmaceuticals.
Restriction: permission of instructor.
781.
Geriatric Medication Management - An Interprofessional Elective.
(2)
A course designed to provide hands-on experiences with geriatric patients in senior centers. Students will work with Nurse Practitioners and nursing students to evaluate blood pressures, blood glucoses, disease states and medication therapy.
782.
Clinical Toxicology.
(2)
Study of the acute toxicity in humans of common drugs, chemicals and household products; physical and laboratory assessment of common poisonings; development of clinical management plans and role of pharmacists in prevention of poisonings. P3 standing in College of Pharmacy.
784.
Advanced Infectious Diseases Pharmacotherapy.
(1)
This course will offer an in-depth discussion of the pharmacotherapy on several infectious diseases related topics such as advanced kinetics, MRSA treatment, liver diseases and infections, and HIV.
Prerequisite: 751 with a grade of "C" or better.
Restriction: permission of instructor.
785.
Advanced Cardiovascular Pharmacotherapy.
(1)
This course is designed to give students an advanced knowledge and skill base in cardiovascular medicine and will include topics designed to allow the student to maximize the learning experience in the Cardiology APPE.
786.
Geriatric Interprofessional Elective.
(2)
This course involves the study of the treatment of common geriatric disease states in multiple care settings and involves case-based discussion with an interprofessional team of students and instructors.
Offered on a CR/NC basis only.
790.
Physical Assessment for the Pharmacist.
(2)
A physical assessment course to include instruction in performing physical assessment exams for all major organ systems, patient interviewing, and documentation for students who are interested in incorporating clinical pharmacy into their future practice.
798.
Problems in Pharmacy.
(1-5 to a maximum of 10 Δ)
Research and library problems in some phases of pharmacy.
Restriction: permission of instructor.
801.
Applied Biochemistry.
(3)
The course covers basic principles of protein, carbohydrate and lipid function, metabolism, and an introduction to molecular mechanisms of drug action.
Restriction: admitted to Pharm.D. program.
802.
Physical Pharmacy and Biopharmaceutics.
(3)
An introduction to physical pharmacy and biopharmaceutical principles impacting drug development and the performance of pharmaceutical dosage forms.
Restriction: admitted to Pharm.D. program.
803.
Aspects of Patient Care I.
(3)
The first in a series of six courses, students are introduced to prescription processing and dispensing as well as patient communication. Drug information retrieval, Top 200 drugs, pharmaceutical calculation, and medical terminology are included.
Restriction: admitted to Pharm.D. program.
804.
Public Health.
(2)
Presents New Mexico public health challenges in which pharmacists play a vital role in improving health of community and local population.
Restriction: admitted to Pharm.D. program.
805.
Fundamentals of Pathophysiology and Immunology.
(3)
The fundamental basics of human pathophysiology and diagnostic tests used to evaluate normal and disease-based biomarkers and the underlying principles of immunology are presented as foundation for in-depth organ-specific disease states discussed in subsequent courses.
Restriction: admitted to Pharm.D. program.
807.
Introduction to Pharmacy Practice and Communication.
(2)
This course will allow students to develop an understanding for the profession, insight into themselves as future health care professionals and enable students to learn the fundamentals of professional communication in healthcare settings.
Restriction: admitted to Pharm.D. program.
809.
Pharmacy and Health Care Delivery Systems.
(2 [3])
Explores the current U.S. healthcare delivery system models from perspective of pharmacy with emphasis on the influences of government policy, regulatory oversight and financial implications.
Restriction: admitted to Pharm.D. program.
810.
Fundamentals of Pharmacokinetics and Dosage Forms.
(3)
An introduction to the influence of absorption, distribution, metabolism, and excretion on the time course of drug levels in body as well as fundamental principles in the design and manufacture of dosage forms.
Restriction: admitted to Pharm.D. program.
811.
Introduction to Pharmacology and Medicinal Chemistry.
(4)
This course will specifically cover an introduction to pharmacology, basics of drug metabolism and the structure-activity relationships (SAR), toxicology and elimination of drugs that act upon the autonomic nervous system.
Restriction: admitted to Pharm.D. program.
813.
Aspects of Patient Care II.
(2 [1])
The second in a series of six courses, students continue dispensing and professional communication skills. Introduction to Pharmacists’ Patient Care Process with self-care products. Basic drug information, Top 200 drugs and non-sterile compounding.
Restriction: admitted to Pharm.D. program.
815.
Integrated Pharmacotherapeutics and Self Care.
(4)
The introductory course to the Integrated Pharmacotherapeutics sequence presents the pathophysiology, pharmacology, medicinal chemistry, and pharmacotherapeutics pertaining to self-care and non-prescription pharmacotherapy.
Restriction: admitted to Pharm.D. program.
817.
Introduction to Law, Ethics and Social Issues in Pharmacy.
(2)
Introduction to pharmacy law with considerations of professional ethics and social determinants of health that impact the professional practice of pharmacy.
Restriction: admitted to Pharm.D. program.
819.
Professional Development I.
(1)
Series of seminars with focus on professionalism, leadership development, career exploration and decision-making, post graduate education opportunities, and contemporary professional practice issues influencing patient care.
Offered on a CR/NC basis only.
Restriction: admitted to Pharm.D. program.
820.
Integrated Pharmacotherapeutics I.
(3)
The first course in the Integrated Pharmacotherapeutics sequence presents the pathophysiology, pharmacology, medicinal chemistry and pharmacotherapeutics as they relate to use in general ambulatory care for cardiology, endocrinology, and pulmonary disease states.
Restriction: admitted to Pharm.D. program.
823.
Aspects of Patient Care III.
(2)
The third in a series of six courses, students focus on the Pharmacists’ Patient Care Plan involving prescription medications, patient history and more complex patient cases.
Restriction: admitted to Pharm.D. program.
824.
Dosage Forms.
(3)
To provide students with an introduction to the fundamental principles of dosage forms, their design and the processes used in manufacturing and compounding drug products.
Restriction: admitted to Pharm.D. program.
825.
Integrated Pharmacotherapeutics II.
(3 [2])
The second course in the Integrated Pharmacotherapy sequence presents the pathophysiology, pharmacology, medicinal chemistry and pharmacotherapeutics as they relate to use in general ambulatory care for endocrinology, musculoskeletal pain and psychiatry.
Restriction: admitted to Pharm.D. program.
828.
Pharmacoepidemiology and Research Design.
(2)
Introduction to basic concepts of pharmacoepidemiology and research study designs used to evaluate health, disease, and drug utilization. Methods of critical evaluation, analysis of biomedical literature, identification of reliable and valid research outcomes are presented.
Restriction: admitted to Pharm.D. program.
829.
Professional Development II.
(1)
Series of seminars with focus on professionalism, leadership development, career exploration and decision-making, post graduate education opportunities, and contemporary professional practice issues influencing patient care.
Offered on a CR/NC basis only.
Restriction: admitted to Pharm.D. program.
830.
Integrated Pharmacotherapeutics III.
(3)
The third course in the Integrated Pharmacotherapy sequence presents the pathophysiology, pharmacology, medicinal chemistry, and pharmacotherapeutics as they relate to antibiotic treatment of bacterial infections.
Restriction: admitted to Pharm.D. program.
832.
Evidence-Based Clinical Decision Making.
(2)
This course develops skills to determine validity, applicability and significance of published clinical research for potential application in optimizing patient care.
Restriction: admitted to Pharm.D. program.
833.
Aspects of Patient Care IV.
(2)
The fourth in a series of six courses, students focus on the Pharmacists’ Patient Care Plan involving prescription medications. Patient History and more complex patient cases.
Restriction: admitted to Pharm.D. program.
835.
Integrated Pharmacotherapeutics IV.
(3)
The fourth course in the Integrated Pharmacotherapeutics sequence presents the pathophysiology, pharmacology, medicinal chemistry and pharmacotherapeutics as they relate to use in complex ambulatory care setting for a variety of disease states.
Restriction: admitted to Pharm.D. program.
836.
Pharmacoeconomics.
(2)
The course covers fundamental concepts in pharmaceutical economic evaluations including decision model analysis. Provide a basic understanding of how to manage resources and optimize healthcare resource allocation with emphasis on drug treatments.
Restriction: admitted to Pharm.D. program.
837.
Pharmacy Management and Operations.
(3)
Introduction to principles, skills, and practices relevant to successful business operation and management in a variety of pharmacy practice settings.
Restriction: admitted to Pharm.D. program.
839.
Professional Development III.
(1)
Series of seminars with focus on professionalism, leadership development, career exploration and decision-making, post graduate education opportunities, and contemporary professional practice issues influencing patient care.
Offered on a CR/NC basis only.
Restriction: admitted to Pharm.D. program.
840.
Integrated Pharmacotherapeutics V.
(2)
The fifth course in the Integrated Pharmacotherapy sequence presents the pathophysiology, pharmacology, medicinal chemistry, and pharmacotherapeutics as they relate to fungal and viral infections.
Restriction: admitted to Pharm.D. program.
842.
Safe Medications and Pharmacy Informatics.
(3)
This course provides a study of the source/existence of medication errors, reasons for these errors and suggested methods (including pharmacy informatics) to prevent them from occurring.
Restriction: admitted to Pharm.D. program.
843.
Aspects of Patient Care V.
(1 [2])
The fifth in a series of six courses, students focus on the Pharmacists’ Patient Care Plan involving prescription medications. Patient History and more complex patient cases.
Restriction: admitted to Pharm.D. program.
845.
Integrated Pharmacotherapeutics VI.
(4)
The sixth course in the Integrated Pharmacotherapeutics sequence presents the pathophysiology, pharmacology, medicinal chemistry, and pharmacotherapeutics as they relate to use in complex ambulatory care for neurological and psychiatric disease states.
Restriction: admitted to Pharm.D. program.
847.
Integrated Pharmacotherapeutics VII.
(2)
The seventh course in the Integrated Pharmacotherapeutics sequence presents the pathophysiology, pharmacology, medicinal chemistry and pharmacotherapeutics as they relate to use in treatment and management of oncological disease states.
Restriction: admitted to Pharm.D. program.
849.
Professional Development IV.
(1)
Series of seminars with focus on professionalism, leadership development, career exploration and decision-making, post graduate education opportunities, and contemporary professional practice issues influencing patient care.
Offered on a CR/NC basis only.
Restriction: admitted to Pharm.D. program.
850.
Integrated Pharmacotherapeutics VIII.
(3)
The eighth course in the Integrated Pharmacotherapeutics sequence presents the pathophysiology, pharmacology, medicinal chemistry and pharmacotherapeutics as they relate to use in complex hospital care for cardiology, nutrition, critical care and clinical toxicology.
Restriction: admitted to Pharm.D. program.
851.
Emerging Trends in Pharmacy.
(1)
A topics course intended to increase student awareness and understanding of contemporary issues related to pharmacy practice, pharmaceutical industry and health care.
Restriction: admitted to Pharm.D. program.
853.
Aspects of Patient Care VI.
(1 [2])
The sixth in a series of six courses, students focus on the Pharmacists' Patient Care Plan involving prescription medications. Patient History and more complex patient cases.
Restriction: admitted to Pharm.D. program.
854.
Advanced Law and Ethics.
(2)
A review of state and federal statutes and regulations governing pharmacy within New Mexico. Compare and contrast current regulation with ethical decision making situations involving health care.
Restriction: admitted to Pharm.D. program.
855.
Clinical Capstone.
(5)
Students will demonstrate professional ability to integrate and apply knowledge of basic sciences, pharmacotherapy, pharmacy practice management, oral/written communication, literature evaluation, drug information retrieval, and pharmacoeconomics in management of patients with multiple medical conditions.
Restriction: admitted to Pharm.D. program.
859.
Professional Development V.
(1)
Series of seminars with focus on professionalism, leadership development, career exploration and decision-making, post graduate education opportunities, and contemporary professional practice issues influencing patient care.
Offered on a CR/NC basis only.
Restriction: admitted to Pharm.D. program.
880.
Direct Patient Care Experience I.
(1)
Students participate in direct-patient care interactions with practitioners and patients advancing patient welfare in authentic practice settings. Participation in Pharmacist Patient Care Process emphasizes patient data collection and assessment for possible medication-related problems.
Offered on a CR/NC basis only.
Restriction: admitted to Pharm.D. program.
881.
Direct Patient Care Experience II.
(1)
Students participate in direct-patient care interactions with practitioners and patients to advance patient welfare in authentic practice settings. Pharmacist Patient Care Process emphasizes medication distribution systems and high quality, interprofessional, and team-based patient care.
Offered on a CR/NC basis only.
Restriction: admitted to Pharm.D. program.
890.
Advanced Community Pharmacy Practice Experience.
(4, may be repeated three times Δ)
This course is a supervised pharmacy experience in an outpatient, community setting. By observing and practicing, students develop skills to be practice- and team-ready.
Restriction: admitted to Pharm.D. program.
891.
Advanced Institutional Pharmacy Practice Experience.
(4, may be repeated three times Δ)
This course is a supervised pharmacy experience in an inpatient or institutional setting. By observing and practicing, students will develop skills to be practice- and team-ready.
Restriction: admitted to Pharm.D. program.
893.
Ambulatory Care Pharmacy Practice Experience.
(4, may be repeated three times Δ)
This course is a supervised pharmacy experience in an outpatient setting. By observing and practicing, students will develop their skills to be practice- and team-ready.
Restriction: admitted to Pharm.D. program.
894.
General and Adult Medicine Advanced Pharmacy Practice Experience.
(4, may be repeated three times Δ)
This course is a supervised pharmacy experience in an adult medicine setting. By observing and practicing, students will develop their skills to be practice- and team-ready.
Restriction: admitted to Pharm.D. program.
895.
Direct Patient Care Pharmacy Practice Experience.
(4, may be repeated three times Δ)
This course is a supervised pharmacy practice experience in an outpatient and/or inpatient setting. By observing and practicing, students will develop skills to be practice- and team-ready.
Restriction: admitted to Pharm.D. program.
896.
Indirect Patient Care Pharmacy Practice Experience.
(4, may be repeated three times Δ)
This course is a supervised pharmacy experience involving no direct patient care. By observing and practicing, students will develop their skills to be practice- and team-ready.
Restriction: admitted to Pharm.D. program.
